Cipherome, Inc. is a unique software-based pharmacogenomics (PGx) and bioinformatics company focused on accurately predicting adverse drug reactions (ADRs). Comprised of a highly credible team with extensive experience in bioinformatics, advanced genomic sequence analysis algorithms, drug development, and clinical expertise, Cipherome has developed a Xentinel ™, a proprietary personalized drug safety and biomarker discovery platform. Our goal is to reduce the economic, emotional, and societal burden of ADRs. Please visit us at www.cipherome.com to learn more about what we do.